Adapsyn Bioscience enters into strategic collaboration with Evotec

/PRNewswire/ - Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic...

Related Keywords

Andrew Andy Haigh ,Adapsyn Bioscience ,Dirk Ullmann ,Linkedin ,Evotec Se Frankfurt Stock Exchange ,Adapsyn Bioscience Inc ,Nasdaq ,Frankfurt Stock Exchange ,Global Head ,Drug Discovery Services ,